These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Will routine therapeutic drug monitoring have a place in clozapine therapy? Freeman DJ; Oyewumi LK Clin Pharmacokinet; 1997 Feb; 32(2):93-100. PubMed ID: 9068925 [TBL] [Abstract][Full Text] [Related]
24. A review of clozapine safety. Fitzsimons J; Berk M; Lambert T; Bourin M; Dodd S Expert Opin Drug Saf; 2005 Jul; 4(4):731-44. PubMed ID: 16011451 [TBL] [Abstract][Full Text] [Related]
25. Successful treatment with clozapine at higher doses after clozapine-induced priapism. de Nesnera A J Clin Psychiatry; 2003 Nov; 64(11):1394-5. PubMed ID: 14658959 [No Abstract] [Full Text] [Related]
26. Clozapine-induced electroencephalogram changes as a function of clozapine serum levels. Freudenreich O; Weiner RD; McEvoy JP Biol Psychiatry; 1997 Jul; 42(2):132-7. PubMed ID: 9209730 [TBL] [Abstract][Full Text] [Related]
27. Examining concentration-dependent toxicity of clozapine: role of therapeutic drug monitoring. Khan AY; Preskorn SH J Psychiatr Pract; 2005 Sep; 11(5):289-301. PubMed ID: 16184070 [TBL] [Abstract][Full Text] [Related]
28. Clozapine induced akathisia: a case report and review of the evidence. Grover S; Sahoo S Indian J Pharmacol; 2015; 47(2):234-5. PubMed ID: 25878393 [TBL] [Abstract][Full Text] [Related]
30. Restarting clozapine after neutropenia: evaluating the possibilities and practicalities. Whiskey E; Taylor D CNS Drugs; 2007; 21(1):25-35. PubMed ID: 17190527 [TBL] [Abstract][Full Text] [Related]
31. [Switching to e-cigarettes affects drug concentration]. Berm EJ; Ruijsbroek R; Loonen AJ; Goethals KR; Wilffert B; van Hasselt F Ned Tijdschr Geneeskd; 2015; 159():A9090. PubMed ID: 26200424 [TBL] [Abstract][Full Text] [Related]
33. A case of clozapine-induced tonic-clonic seizures managed with valproate: implications for clinical care. Foster R; Olajide D J Psychopharmacol; 2005 Jan; 19(1):93-6. PubMed ID: 15671134 [TBL] [Abstract][Full Text] [Related]
35. Increased risk of side-effects in psychiatric patients treated with clozapine and carbamazepine: a reanalysis. Langbehn DR; Alexander B Pharmacopsychiatry; 2000 Sep; 33(5):196. PubMed ID: 11071023 [No Abstract] [Full Text] [Related]
36. Clinical pharmacokinetics of atypical antipsychotics: a critical review of the relationship between plasma concentrations and clinical response. Mauri MC; Volonteri LS; Colasanti A; Fiorentini A; De Gaspari IF; Bareggi SR Clin Pharmacokinet; 2007; 46(5):359-88. PubMed ID: 17465637 [TBL] [Abstract][Full Text] [Related]
37. Clozapine-Associated Pulmonary Embolism: A High-Mortality, Dose-Independent and Early-Onset Adverse Effect. Sarvaiya N; Lapitskaya Y; Dima L; Manu P Am J Ther; 2018; 25(4):e434-e438. PubMed ID: 29985823 [TBL] [Abstract][Full Text] [Related]
38. Successful electroconvulsive therapy and improvement of negative symptoms in refractory schizophrenia with clozapine-induced seizures: a case report. Park S; Lee MK Psychiatr Danub; 2014 Dec; 26(4):360-2. PubMed ID: 25377372 [No Abstract] [Full Text] [Related]